Autopsy report · NCT04283058

Low Dose Ketamine Infusion for the Treatment of Resistant Depression

“Covid-19 disruption of team”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Sponsor

Loma Linda University

Sponsor type

University, hospital or other

Conditions

Depression

Interventions

Ketamine

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• A Comparison of Stryker's Tritanium Posterior Lumbar Cage and PEEK Implant
  “Due to COVID-19 disruption” (79% match in meaning)
• A Personalized Prehabilitation Intervention In Elective Joint Replacement Surgery
  “Covid-19 Crisis” (73% match in meaning)
• Efficacy of Two Local Anesthetics on Quality of Life After Endodontic Treatment
  “COVID-19 and Personnel changes” (72% match in meaning)
• B1 and Magnesium Supplements on Glucose Metabolism in Low-carb Dieters
  “COVID-19 pandemic” (69% match in meaning)
• OpenGo Sensor Insole in Open Wedge HTO
  “Technical issues, COVID-19” (69% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.